• You are here :
  • Home

All news

Wed 11 April 2012

Dental Moving raises funds and widens its offer

dental moving

Created in June 2010, this new R&D company for dental solutions, assisted by Atlanpole, raises 400 000 Euros to private investors. At the end of 2011, Dental-Moving launched Easy Macro View (EMV), the first intra-buccal endoscope equipped with a sensor with a diameter of only 3,4 millimeters. Bringing real clinical help and comfort to the dental practitioners, EMV is used at a distance of only 12 mm from the area to treat and thus enables the practitioners to look very closely the pathology which is to be treated.

Fri 23 March 2012

In-Cell-Art will receive € 1.2 million to support the field of infectious diseases

In Cell Art

In-Cell-Art, a company member of Atlanpole Biotherapies, is involved in a collaborative project called EMER IT. This project will apply In-Cell-Art’s nanocarrier technologies to the development of specific polyclonal immunoglobulins [F(ab’)2] against life-threatening pathogens such as Ebola, Nipah, or Avian Flu H5N1. This consortium will also develop and validate DNA vaccines formulated with In-Cell-Art’s nanocarriers against an equine infection. These projects will lead to the proof of concept about the new applications of In-Cell-Art’s nanocarrier technologies for immunization against life-threatening pathogens, safe immunogen production, and horse vaccination.

Wed 07 March 2012

Licensing : transforming innovation into a product

On March 7th & 8th this year, Atlanpole, Atlanpole Biotherapies and the French LES (Licensing Executive Society) organized a training session in licensing for innovative companies. Report.

Tell us your news